by 21st Century Competition | May 28, 2014 | Global Blogs
Swiss food conglomerate Nestle is reportedly expanding its skincare portfolio after acquiring various injectable treatment patents in a $1.4 billion deal. Reports say Nestle acquired the rights for various wrinkle treatments from Valeant Pharmaceuticals. While the...
by 21st Century Competition | May 28, 2014 | Global Blogs
Once at the top of its game, advisor Nomura Holdings is now facing one of its biggest slumps as the merger deal that was supposed to be its largest of the year suddenly imploded. According to reports, Nomura, Japan’s largest securities firm, is set to have its...
by 21st Century Competition | May 28, 2014 | Global Blogs
Valeant Pharmaceuticals has reportedly upped its unsolicited offer to acquire the maker of Botox. Reports say Valeant increased its bid to $49.4 billion to acquire Canada-based Allergan in hopes of swaying approval from the firm and its shareholders. The original...
by 21st Century Competition | May 28, 2014 | Global Blogs
Italy’s health regulator is reportedly seeking damages worth nearly$2 billion from three of the world’s largest pharmaceutical firms for their repeated antitrust violations and subsequent harm on the nation’s health industry. According to reports,...
by 21st Century Competition | May 28, 2014 | Global Blogs
Facebook has reportedly requested a full investigation into its proposed acquisition of messaging application WhatsApp by the European Commission, according to reports. The social media giant wants the Commission to review the $19 billion merger in hopes of bypassing...
